Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 3
2021 8
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Circulating Biomarkers for Tumor Angiogenesis: Where Are We?
Di Paolo V, Colletti M, Ferruzzi V, Russo I, Galardi A, Alessi I, Milano GM, Di Giannatale A. Di Paolo V, et al. Among authors: alessi i. Curr Med Chem. 2020;27(14):2361-2380. doi: 10.2174/0929867325666180821151409. Curr Med Chem. 2020. PMID: 30129403 Review.
Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management.
Del Baldo G, Carta R, Alessi I, Merli P, Agolini E, Rinelli M, Boccuto L, Milano GM, Serra A, Carai A, Locatelli F, Mastronuzzi A. Del Baldo G, et al. Among authors: alessi i. Front Oncol. 2021 Feb 22;11:586288. doi: 10.3389/fonc.2021.586288. eCollection 2021. Front Oncol. 2021. PMID: 33692948 Free PMC article. Review.
Short and Long-Term Toxicity in Pediatric Cancer Treatment: Central Nervous System Damage.
Alessi I, Caroleo AM, de Palma L, Mastronuzzi A, Pro S, Colafati GS, Boni A, Della Vecchia N, Velardi M, Evangelisti M, Carboni A, Carai A, Vinti L, Valeriani M, Reale A, Parisi P, Raucci U. Alessi I, et al. Cancers (Basel). 2022 Mar 17;14(6):1540. doi: 10.3390/cancers14061540. Cancers (Basel). 2022. PMID: 35326692 Free PMC article. Review.
Long-term response to crizotinib in a 17-year-old boy with treatment-naïve ALK-positive non-small-cell lung cancer.
Megaro G, Miele E, Spinelli GP, Alessi I, Del Baldo G, Cozza R, Russo I, De Pasquale MD, Cefalo MG, Tomà P, Carai A, Di Ruscio V, De Ioris MA, Mastronuzzi A. Megaro G, et al. Among authors: alessi i. Cancer Rep (Hoboken). 2022 Mar;5(3):e1483. doi: 10.1002/cnr2.1483. Epub 2022 Jan 28. Cancer Rep (Hoboken). 2022. PMID: 35092185 Free PMC article.
19 results